US regulators warn on Glaxo asthma drug

US drugs industry regulators yesterday said they would slap warning labels on one of GlaxoSmithKline's most established asthma treatments after about 45 African-American patients suffered severe attacks, some causing death, during a 28-week routine test.
Comments on article "US regulators warn on Glaxo asthma drug"
Name Views and CommentsDate
Linda Rescic I took myself off of Serevent because of the chronic and severe attacks. I was also intubated for five days because of this medicine and the ignorant doctors who receive their kickbacks from the pharmaceutical conglomerates. I am now only taking one puff of Flovent in the morning and one puff of Flovent in the evening. Before this self-reduction I was a walking medicine cabinet for the corporate medical system in the US.
11/3/2003
Linda Rescic I took myself off of Serevent because of the chronic and severe attacks. I was also intubated for five days because of this medicine and the ignorant doctors who receive their kickbacks from the pharmaceutical conglonmerates. I am now only taking one puff of Flovent in the morning and one puff of Flovent in the evening. Before this self-reduction I was a walking medicine cabinet for the corporate medical system in the US.
11/3/2003
Use the feedback form below to submit your comments.
Your Comments:
Your Name:
Use the form below to email this article to your friends.
Recipient Email Address:
 Separate multiple email addresses by ;
Your Name:
Your Email Address: